Congress Asset Management CO Editas Medicine, Inc. Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

A detailed history of Congress Asset Management CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 89,557 shares of EDIT stock, worth $108,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,557

Previous 90,496 1.04%

Holding current value

$108,363

Previous $422,000 27.73%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$3.39 - $5.96 $3,183 - $5,596	-939 Reduced 1.04%	89,557 $305,000
Q2 2024 Aug 02, 2024	SELL	$4.67 - $7.28 $5,300 - $8,262	-1,135 Reduced 1.24%	90,496 $422,000
Q1 2024 Apr 11, 2024	BUY	$7.03 - $11.07 $8,379 - $13,195	1,192 Added 1.32%	91,631 $679,000
Q4 2023 Mar 04, 2024	BUY	$6.25 - $11.11 $1,281 - $2,277	205 Added 0.23%	90,439 $916,000
Q3 2023 Nov 01, 2023	BUY	$6.92 - $9.31 $830 - $1,117	120 Added 0.13%	90,234 $703,000
Q2 2023 Jul 27, 2023	BUY	$6.36 - $11.47 $3,593 - $6,480	565 Added 0.63%	90,114 $741,000
Q1 2023 Apr 21, 2023	BUY	$7.03 - $11.53 $62,159 - $101,948	8,842 Added 10.96%	89,549 $649,000
Q4 2022 Jan 18, 2023	BUY	$8.32 - $13.21 $5,308 - $8,427	638 Added 0.8%	80,707 $0
Q3 2022 Nov 08, 2022	BUY	$12.16 - $19.42 $12,208 - $19,497	1,004 Added 1.27%	80,069 $980,000
Q2 2022 Aug 02, 2022	BUY	$9.99 - $21.35 $6,213 - $13,279	622 Added 0.79%	79,065 $935,000
Q1 2022 Apr 20, 2022	BUY	$14.08 - $27.63 $107,951 - $211,839	7,667 Added 10.83%	78,443 $1.49 Million
Q4 2021 Jan 28, 2022	BUY	$26.55 - $40.57 $557 - $851	21 Added 0.03%	70,776 $1.88 Million
Q3 2021 Nov 08, 2021	BUY	$39.27 - $72.94 $105,047 - $195,114	2,675 Added 3.93%	70,755 $2.91 Million
Q2 2021 Aug 05, 2021	BUY	$31.29 - $56.64 $326,667 - $591,321	10,440 Added 18.11%	68,080 $3.86 Million
Q1 2021 May 05, 2021	BUY	$39.71 - $90.58 $2.29 Million - $5.22 Million	57,640 New	57,640 $2.42 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Editas Medicine, Inc. Transaction History